Equities

Recursion Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RXRX:BRN

Recursion Pharmaceuticals Inc

Actions
  • Price (CHF)3.69
  • Today's Change0.00 / 0.00%
  • Shares traded400.00
  • 1 Year change--
  • Beta0.9778
Data delayed at least 15 minutes, as of Jan 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Recursion Pharmaceuticals Inc (RXRX:BRN) closed at 3.69, 5.73% above its 52-week low of 3.49, set on Jan 06, 2026.
52-week range
Today
3.49Jan 06 20264.49Aug 19 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open3.69
High3.69
Low3.69
Bid3.83
Offer3.85
Previous close3.69
Average volume--
Shares outstanding519.84m
Free float493.62m
P/E (TTM)--
Market cap1.85bn USD
EPS (TTM)-1.81
USD
Data delayed at least 15 minutes, as of Jan 16 2026.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.